A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies

Atif M. Hussein, William P. Petros, Maureen Ross, James J. Vredenburgh, Mary Lou Affronti, Roy B. Jones, Elizabeth J. Shpall, Peter Rubin, Maha Elkordy, Colleen Gilbert, Caroline Gupton, Merrill J. Egorin, John Soper, Andrew Berchuck, Daniel Clarke-Pearson, Donald A. Berry, William P. Peters